Prodia | $15,000,000 | (Jul 3, 2024)
BoldHue, Inc. | $3,400,000 | (Jul 3, 2024)
Redactive | $7,500,000 | (Jul 3, 2024)
Perpetual Medicines
China
- Shanghai
- 01/12/2023
- Seed
- $8,000,000
About Perpetual Medicines
Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics including MD simulation, FEP, and quantum chemistry with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We will also couple this “dry” platform with large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Our vision is to disrupt the enormous 40bn-a-year peptide drug market by heralding in a new renaissance in peptide discovery, design & development.
- Industry Biotechnology Research
- Website https://perpetualmeds.com/index
- LinkedIn https://www.linkedin.com/company/perpetual-medicines/about/
Related People
Kerry BlanchardCo Founder
China -
Jing'an District, Shanghai
Drug discovery and development, cell cycle regulation and control, biology of hypoxia, epigenetics, cancer genetics, translational science
Vida Global | $3,000,000 | (Jul 3, 2024)
Steep | $4,303,680 | (Jul 3, 2024)
Cluby | $3,117,935 | (Jul 3, 2024)
Watchyourhealth.com | $5,000,000 | (Jul 3, 2024)
Tembo(US) | $14,000,000 | (Jul 3, 2024)
Wify Technologies | $2,993,443 | (Jul 2, 2024)
Blueroomcare Business | Undisclosed Amount | (Jul 2, 2024)
Comet(INDIA) | $5,000,000 | (Jul 2, 2024)
Cautio | $778,300 | (Jul 2, 2024)